MedPath
FDA Approval

METHOCARBAMOL

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Direct_Rx
DUNS: 079254320
Effective Date
June 6, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Methocarbamol(750 mg in 1 1)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Direct_Rx

079254320

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Direct_Rx

Direct_Rx

Direct_Rx

079254320

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

METHOCARBAMOL

Product Details

NDC Product Code
61919-903
Application Number
ANDA090200
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
June 6, 2023
STEARIC ACIDInactive
Code: 4ELV7Z65APClass: IACT
POLYETHYLENE GLYCOL, UNSPECIFIEDInactive
Code: 3WJQ0SDW1AClass: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141JClass: IACT
POVIDONE K90Inactive
Code: RDH86HJV5ZClass: IACT
Code: 125OD7737XClass: ACTIBQuantity: 750 mg in 1 1
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2Class: IACT
HYDROXYPROPYL CELLULOSE (1600000 WAMW)Inactive
Code: RFW2ET671PClass: IACT
© Copyright 2025. All Rights Reserved by MedPath